Theravance Biopharma, Inc. (TBPH) Net Income by Year
Theravance Biopharma, Inc. reported $105.9M in net income in fiscal year 2025. This represents an increase of 287.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $53.8M in net income. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Theravance Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TBPH Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $53.8M | $105.9M+287.7% | -$56.4M-2.2% | -$55.2M-106.3% | $872.1M+537.3% | -$199.4M+28.3% | -$278.0M-17.6% | -$236.5M-9.7% | -$215.5M+24.5% | -$285.4M-49.7% | -$190.7M-4.6% | -$182.2M+23.1% | -$237.0M | N/A | -$9.6M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
TBPH Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Theravance Biopharma, Inc. financials
Frequently Asked Questions
What was Theravance Biopharma, Inc.'s net income in fiscal year 2025?
Theravance Biopharma, Inc. reported $105.9M in net income in fiscal year 2025.
How fast is Theravance Biopharma, Inc.'s net income growing?
Theravance Biopharma, Inc. (TBPH) net income rose by 287.7% year over year, from -$56.4M to $105.9M in fiscal year 2025.
What is Theravance Biopharma, Inc.'s net income over the last twelve months?
Theravance Biopharma, Inc. (TBPH) reported $53.8M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Theravance Biopharma, Inc.'s net income changed over the years?
Across the 14 fiscal years this page covers, Theravance Biopharma, Inc. (TBPH) net income went from -$9.6M in fiscal year 2012 to $105.9M in fiscal year 2025.
What was Theravance Biopharma, Inc.'s net income in the most recent quarter?
Theravance Biopharma, Inc. (TBPH) reported -$5.9M in net income in Q2 2026. This represents a decrease of 110.8% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Theravance Biopharma, Inc. (TBPH) reported on that line in every period on record.